Average Co-Inventor Count = 5.32
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Medicines Company (6 from 26 patents)
2. Abbvie Inc. (3 from 823 patents)
3. Melinta Therapeutics, Inc. (3 from 24 patents)
4. Chiesi Farmaceutici S.p.a. (2 from 330 patents)
5. The Medicines Company (Leipzig) Gmbh (1 from 16 patents)
6. Targanta Therapeutics, Inc. (1 from 4 patents)
13 patents:
1. 10864249 - High purity oritavancin and method of producing same
2. 10328118 - High purity oritavancin and method of producing same
3. 10201587 - Methods of inhibiting and treating biofilms using glycopeptide antibiotics
4. 10039780 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
5. 9700575 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
6. 9649352 - High purity oritavancin and method of producing same
7. 9439921 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
8. 9295687 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
9. 8946144 - Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
10. 8901072 - Glycopeptide and lipoglycopeptide antibiotics with improved solubility
11. 8524691 - Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
12. 8497245 - Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa
13. 8404664 - Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections